diamsar chelate has been researched along with Prostatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, H; Conti, PS; Huang, CW; Li, Z; Shahinian, T | 1 |
1 other study(ies) available for diamsar chelate and Prostatic Neoplasms
Article | Year |
---|---|
Biological stability evaluation of the α2β1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide.
Topics: Animals; Cell Line, Tumor; Copper Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Integrin alpha2beta1; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Prostatic Neoplasms; Sarcosine; Tissue Distribution; Xenograft Model Antitumor Assays | 2011 |